Sep 15, 2023, 18:51
Michail Ignatiadis: Join us tomorrow with Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib
Quoting Michail Ignatiadis,
Jules Bordet Institute, on Twitter:“Join us tomorrow with Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib, ESMO Virtual Plenary with AACR Expert Commentary: September 2023″
For details click here.
Source: Michail Ignatiadis/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 16, 2025, 17:18
Jan 16, 2025, 16:45
Jan 16, 2025, 16:28
Jan 16, 2025, 16:10
Jan 16, 2025, 16:03
Jan 16, 2025, 15:57
Jan 16, 2025, 15:50
Jan 16, 2025, 15:46